Immunomedics (NASDAQ: IMMU) Dr. Charles Baum, President and Chief Executive Officer (CEO) of Mirati Therapeutics, Inc. has joined the Immunomedics ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News Management Changes

Immunomedics (IMMU) Dr. Charles Baum to Board; Appoints Dr. Behzad Aghazadeh to Executive Chairman Replacing CEO Michael PehlFebruary 26, 2019 5:50 AM Immunomedics Reports Results For Period Ended December 31, 2018, Strengthens Board And Announces Senior Leadership ChangesFebruary 25, 2019 4:01 PM